Chemotherapy of tuberculosis: An updates
Journal Title: Innovations in Pharmaceuticals and Pharmacotherapy (IPP) - Year 2015, Vol 3, Issue 1
Abstract
This review examines the chemotherapy of tuberculosis (TB) in humans which will help in the understanding and treatment of the disease. Tuberculosis is spread primarily by inhalation of aerosolized infectious droplet nuclei of Mycobacterium tuberculosis (MTb) from patients with active pulmonary TB. The most common manifestation of TB in humans is pulmonary disease, but other organs are involved. TB is treated with a combination of anti-tubercular medications given simultaneously such as isoniazide, refampicin, pyrizinamide and ethambutol. The last new drug for treating MTb infections was rifampicin, introduced in 1972. Its use led to development of the short-course regimen, which forms the backbone of the highly effective Directly Observed Treatment Shortcourse (DOTS) strategy. But, the DOTS strategy has its problems. Drug toxicity, the long duration of therapy, and the emergence of multi-drug resistant strains of MTb have highlighted an urgent need for new tools. New drugs that are better tolerated, that permit intermittent chemotherapy, or that affect cure in a shorter time would have a significant impact, making it easier and less expensive to deliver the DOTS strategy. By spending less time on therapy and reducing the number of treatment failures, savings in the cost of providing healthcare can be made which will help in the control of the disease.
Authors and Affiliations
Anochie Philip Ifesinachi,
Keywords
Related Articles
- EP ID EP567629
- DOI -
- Views 117
- Downloads 0
Synthesis of chalcone and fused rhodanine derivatives of biphosphonates active as anti-inflammatory and over breast cancer
There has been considerable interest for medicinal chemist in development of a promising target for new drug development. Rhodanine, thiazolidinedione (TZD) family pharmacophore, is with diverse biological activity. Chal...
Formulation and development of orodispersible tablets of lornoxicam by using resinate inclusion complexes
Lornoxicam is a non-steroidal anti-inflammatory drug and it belongs to the class of oxicam. It is used for potent inhibitor of both COX-1 and COX-2. But it is a very bitter drug and insoluble in water. Aim: To mask the t...
Neuroprotective potential of vinpocetine in epilepsy induced co-morbid depression & cognitive dysfunction in PTZ kindled rats
Epilepsy is a chronic neurological disorder and generally associated with certain psychiatric comorbidities. Among several comorbidities depressive behavior and cognitive impairment has been reported to be most debilitat...
Impact of Oberon (insecticide) and remedial impact of Tulsi (Ocimum sanctum) on hematological parameters of air-breathing fish Channa punctatus
Aim: Indiscriminate use of insecticides has increased many folds in the recent times. Farmers for the better yield of crops, are widely utilising the pesticides. These pesticides through agricultural run offs have reache...
Socioeconomic burden of rheumatic heart disease: An insightful look at in Indian population
Rheumatic heart disease (RHD) continues to be a major health hazard in most developing countries. RHD describes a group of short-term (acute) and long-term (chronic) heart disorders that occur as a result of acute rheuma...